REPORT ID 5370

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Research Report 2017

Publish Date
21-Dec-17
Pages
105
Format
Electronic (PDF)

In this report, the global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Astellas Pharmaceuticals
    Actavis
    Pfizer
    GlaxoSmithKline
    Salix Pharmaceuticals Ltd
    AstraZenenca
    ...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Preface
    Eluxadoline
    Alosetron
    Rifaximin
    Loperamide
    Diphenoxylate + Atropine
    Dicyclomine and Hyoscyamine
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Hospitals
    Clinics
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Research Report 2017
1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Overview
    1.1 Product Overview and Scope of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
    1.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Type (Product Category)
        1.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share by Type (Product Category) in 2016
        1.2.3 Preface
        1.2.4 Eluxadoline
        1.2.5 Alosetron
        1.2.6 Rifaximin
        1.2.7 Loperamide
        1.2.8 Diphenoxylate + Atropine
        1.2.9 Dicyclomine and Hyoscyamine
    1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Application
        1.3.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market by Region (2012-2022)
        1.4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (2012-2022)
        1.5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Status and Outlook (2012-2022)
        1.5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production Status and Outlook (2012-2022)

2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Competition by Manufacturers
    2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production and Share by Manufacturers (2012-2017)
    2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Competitive Situation and Trends
        2.5.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Concentration Rate
        2.5.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity and Market Share by Region (2012-2017)
    3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production and Market Share by Region (2012-2017)
    3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Region (2012-2017)
    4.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export, Import (2012-2017)
    4.4 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export, Import (2012-2017)
    4.7 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export, Import (2012-2017)

5 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue (Value), Price Trend by Type
    5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production and Market Share by Type (2012-2017)
    5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Type (2012-2017)
    5.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Type (2012-2017)
    5.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth by Type (2012-2017)

6 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis by Application
    6.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Market Share by Application (2012-2017)
    6.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturers Profiles/Analysis
    7.1 Astellas Pharmaceuticals
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Actavis
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Pfizer
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 GlaxoSmithKline
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Salix Pharmaceuticals Ltd
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 AstraZenenca
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    ...

8 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Cost Analysis
    8.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast (2017-2022)
    12.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price and Trend Forecast (2017-2022)
    12.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer